Topics include the efficacy and safety of third-line treatment regimens in resource-limited settings, viral rebound rates after treatment interruption of modern ART, and whether a standardized frailty score can improve clinicians’ ability to estimate cardiovascular risk among older people with HIV.
Researchers from UCLA, Harvard Medical School and the University of Tokyo found that during a recent six-year period, homeless people in New York state were more likely to hospitalized and treated with mechanical ventilators for respiratory infections than people who are not homeless. These findings have implications for the COVID-19 pandemic.
UCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.
Dr. Clara Lajonchere, deputy director of the Institute for Precision Health at UCLA Health, has been elected chair of the new California Precision Medicine Advisory Council.
In the June 11 issue of the New England Journal of Medicine, a team of UCLA physicians and scientists describes the first case of immune modulation being used to cure a severe and often fatal fungal infection. The team “retuned” a 4-year-old’s immune system so that it could fight off disseminated coccidioidomycosis.
UCLA Health has been granted permission from the Food and Drug Administration to use a 3D printed design for COVID-19 testing swabs. The effort was led by a fellow from the UCLA Biodesign program.
Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group — known as Gleason grade group 5 — and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences. The findings may affect how people are treated for the disease.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
A UCLA research team has identified a new paradigm for understanding the regulation of the immune system, potentially paving the way for new approaches to treating infections and immune-related diseases such as type 1 diabetes and certain cancers.
Half of apartment dwellers in Los Angeles report having been exposed to unwanted secondhand smoke in their homes in the last year, and 9 in 10 of them say they favor policies banning smoking from their buildings, a new study by researchers at the Fielding School of Public Health's UCLA Center for Health Policy Research reveals.
UCLA Asian American Studies Center and the UCLA Fielding School of Public Health COVID-19 Multilingual Resource Hub to support safety for diverse communities; partnership develops resources for COVID-19 response
A new study from researchers at the UCLA Jonsson Comprehensive Cancer Center helps explain how disruptions in genes can lead to the resistance to one of the leading immunotherapies, PD-1 blockade, and how new drug combinations could help overcome resistance to the anti-PD-1 therapy in a mechanistically-based way.
A $1 million gift from the Shurl and Kay Curci Foundation will support the UCLA COVID-19 Rapid Response Initiative, a partnership of the UCLA Fielding School of Public Health and the David Geffen School of Medicine at UCLA.
A team of researchers from the UCLA Jonsson Comprehensive Cancer Center and peer institutions has been awarded a $5.75 million grant from the National Cancer Institute to study the correlation between obesity, inflammation and pancreatic cancer. The scientists hope their findings may help people avoid getting this cancer.
A new UCLA study in zebrafish has identified the process by which air pollution can damage brain cells, potentially contributing to Parkinson’s disease.
UCLA researchers have launched a new clinical trial that uses a hormone suppresser commonly used to treat men with prostate cancer to help improve clinical outcomes for men infected with COVID-19.
The AIDS Clinical Trials Group (ACTG) has initiated a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19.
A team at UCLA is training thousands of individuals across the state in public health techniques and strategies, including contact tracing, case investigation, and administration, in order to mitigate the spread of COVID-19.
For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.
Much attention has been paid to the devastating effects of COVID-19 on the lungs. But doctors are learning how the virus may affect other organs, including the brain.
LOS ANGELES COUNTY: Six of Los Angeles County’s largest nonprofit health systems with hospitals, clinics and care facilities across the region have come together united in a mission to encourage community members to put health first and access care when needed.
An interdisciplinary team of researchers at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA has developed a first-of-its-kind roadmap of how human skeletal muscle develops, including the formation of muscle stem cells.
The UCLA Fielding School of Public Health has launched FIELDING FOCUS, a webinar discussion series that has begun with weekly curated conversations addressing public health and COVID-19. In past sessions, we have explored the impact that the current pandemic is having on health care management (April 28) and vulnerable populations (May 5); in this upcoming (May 12) session, on wellness and healthy living. Additional sessions are in the planning stages.
Note: Embargoed until 8 a.m. PDT Monday, May 11, 2020. Paid Sick Leave a Crucial Weapon During COVID-19 Era and Beyond, UCLA Study Finds. A UCLA analysis of policies in 193 countries shows that gaps in coverage for ill workers put nations’ health and economic security at risk. The research is to be published May 11 in in the journal Global Public Health.
To keep patients and health-care providers safe from COVID-19, while providing urgent treatment to stroke patients, extra precautions must be taken, according to new guidelines published in the journal Stroke.
UCLA Health initiative to unite Los Angeles with four key goals: raise the collective civic spirit, encourage responsible behaviors like maintaining good health, acknowledge the hardships that COVID-19 has presented and show gratitude to local MVPs and heroes.
UCLA Fielding School of Public Health research investigates COVID-19 case rates and pandemic protection: A metric for decisions to implement, continue, or relax measures.
Will our clean air last after COVID-19? UCLA study says it’s possible. Achieving net-zero emissions in California by 2050 can prevent thousands of deaths annually — in every community — researchers say
The UCLA Fielding School of Public Health has launched FIELDING FOCUS, a webinar discussion series that has begun with weekly curated conversations addressing public health and COVID-19. During upcoming sessions, we will explore the impact that the current pandemic is having on vulnerable populations (May 5) and on wellness and healthy living (May 12). Additional sessions are in the planning stages.
UCLA researchers found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors.
The David Geffen School of Medicine at UCLA is leading a project in collaboration with the University of Iowa Carver College of Medicine to study ways to reduce the risk for COVID-19 infection among emergency department workers.
UCLA is one of seven sites participating in a clinical trial investigating whether hydroxychloroquine, a commonly used anti-malarial and autoimmune drug, can prevent infection with COVID-19.
A new UCLA study suggests the general public does not fully grasp the meaning of the terms "futile treatment" or "potentially inappropriate treatment," although the concept is important to understand so that families can make fully informed decisions for their loved ones.
When the COVID-19 outbreak became a pandemic, and the scarcity of testing supplies became a crisis, the leaders of UCLA Biodesign saw the experience and background of Gabriel Oland, MD, as the ideal combination to help reinforce one link in the strained supply chain: the nasopharyngeal swabs used to collect patient specimens for testing.
Researchers from the UCLA Jonsson Comprehensive Cancer Center received a $2.8 million, five-year grant from the National Cancer Institute to help develop a blood-based test to improve the selection and prioritization for patients with liver cancer who need a liver transplantation.
Three researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received awards to pursue treatments and vaccines for COVID-19 from the California Institute for Regenerative Medicine, the state’s stem cell agency.
The UCLA Fielding School of Public Health will host executives from Cedars-Sinai and Kaiser Permanente and academic experts from UCLA and Arizona State University to discuss COVID-19 & Health Care Management.
Un grupo de investigadores de la Universidad de California Los Ángeles (UCLA), ha desarrollado una aplicación web que permite a todo el mundo ayudar en la lucha contra el coronavirus.
UCLA researchers identify a possible new drug that could help prevent cognitive decline in people who undergo radiation therapy for brain tumors.
UCLA has joined a nationwide effort to study whether convalescent plasma collected from people who have recovered from COVID-19 may yield a treatment for the deadly virus.
n the years after 2014, when the Affordable Care Act’s health insurance marketplaces were established, low-income patients who underwent a surgical procedure saved an average of $601 in out-of-pocket spending and $968 in premium spending per year, compared to before the marketplaces existed. Those low-income patients also had a 35% lower chance of having catastrophic levels of household medical spending. However, for middle-income patients, spending levels were about the same before and after the marketplaces began.
A new national registry has been launched by specialists in obstetrics, gynecology and reproductive sciences at UCLA Health and the University of California, San Francisco, to determine COVID-19’s possible effects on pregnant women and newborns.
Media teleconference sponsored by the Robert Wood Johnson Foundation, Friday, April 10th, at Noon ET / 9 AM PT
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right